{"transactions":[{"id":730378,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-22T20:24:06.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":49579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 17, 2027, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":49579,"derivative":{"exercise_price":1.13,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":49579},"source":{"system":"sec-edgar","filing":"0000905148-26-003050","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000090514826003050/form4.xml","form_type":"4"}},{"id":730377,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T20:24:06.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":30421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 17, 2027, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":80998,"source":{"system":"sec-edgar","filing":"0000905148-26-003050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000090514826003050/form4.xml","form_type":"4"}},{"id":1103596,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-23T22:34:43.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":50790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 18, 2026, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":50790,"derivative":{"exercise_price":2.11,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":50790},"source":{"system":"sec-edgar","filing":"0000905148-25-002229","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000090514825002229/form4.xml","form_type":"4"}},{"id":1103595,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-23T22:34:43.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":29210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 18, 2026, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":50577,"source":{"system":"sec-edgar","filing":"0000905148-25-002229","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000090514825002229/form4.xml","form_type":"4"}},{"id":1480417,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-13T21:30:16.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":40701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":40701,"derivative":{"exercise_price":4.68,"expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":40701},"source":{"system":"sec-edgar","filing":"0001415889-24-016708","document":"form4-06132024_090610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924016708/form4-06132024_090610.xml","form_type":"4"}},{"id":1480416,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-13T21:30:16.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":21367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":21367,"source":{"system":"sec-edgar","filing":"0001415889-24-016708","document":"form4-06132024_090610.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924016708/form4-06132024_090610.xml","form_type":"4"}},{"id":1845050,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T21:25:31.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 22, 2024, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":4.57,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-23-039457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000120919123039457/doc4.xml","form_type":"4"}},{"id":2099928,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-12-01T21:43:29.000Z","date":"2022-11-30","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. 1/3rd of the shares underlying this option vest on November 30, 2023 and the remaining 2/3rds vest in 24 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer as of each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":5.99,"expiration_date":"2032-11-29","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-22-059200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000120919122059200/doc4.xml","form_type":"4"}},{"id":2791638,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:36:01.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":9494,"price":9.04,"value":85825.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":12.96,"expiration_date":"2030-06-24","underlying":"Ordinary Shares","underlying_shares":9494},"source":{"system":"sec-edgar","filing":"0001140361-21-008343","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1284839/000114036121008343/form4.xml","form_type":"4"}},{"id":2791637,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:36:01.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":7457,"price":7.56,"value":56374.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":14.44,"expiration_date":"2029-06-18","underlying":"Ordinary Shares","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001140361-21-008343","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1284839/000114036121008343/form4.xml","form_type":"4"}},{"id":2791636,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:36:01.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":7457,"price":7.51,"value":56002.07,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":14.49,"expiration_date":"2028-06-19","underlying":"Ordinary Shares","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001140361-21-008343","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1284839/000114036121008343/form4.xml","form_type":"4"}},{"id":2791635,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:36:01.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":7457,"price":7.54,"value":56225.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":14.46,"expiration_date":"2027-06-06","underlying":"Ordinary Shares","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001140361-21-008343","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1284839/000114036121008343/form4.xml","form_type":"4"}},{"id":2791634,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:36:01.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":7457,"price":13.35,"value":99550.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":8.65,"expiration_date":"2026-06-28","underlying":"Ordinary Shares","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001140361-21-008343","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1284839/000114036121008343/form4.xml","form_type":"4"}},{"id":2791633,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:36:01.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":14914,"price":10.38,"value":154807.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":11.62,"expiration_date":"2026-01-29","underlying":"Ordinary Shares","underlying_shares":14914},"source":{"system":"sec-edgar","filing":"0001140361-21-008343","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1284839/000114036121008343/form4.xml","form_type":"4"}},{"id":2791632,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:36:01.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":3728,"price":10.38,"value":38696.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":11.62,"expiration_date":"2026-01-29","underlying":"Ordinary Shares","underlying_shares":3728},"source":{"system":"sec-edgar","filing":"0001140361-21-008343","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1284839/000114036121008343/form4.xml","form_type":"4"}},{"id":2791631,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-03-12T21:36:01.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":8081,"price":22,"value":177782.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed pursuant to the acquisition by PerkinElmer (UK) Holdings Limited of the entire issued share capital of Oxford Immunotec Global PLC on March 8, 2021 by means of a scheme of arrangement under Part 26 of the Companies Act 2006 (the \"Scheme\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-21-008343","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1284839/000114036121008343/form4.xml","form_type":"4"}},{"id":3098370,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true}}],"security":"Share Option (Right to Buy)","published_at":"2020-06-26T20:05:11.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":9494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Options granted under Issuer's 2013 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option will vest and become exercisable as to 100% of the underlying shares on the earlier of the first anniversary of the date of grant or the date of the first annual general meeting of the shareholders held after the date of grant."}],"balance_after":9494,"derivative":{"exercise_price":12.96,"expiration_date":"2030-06-24","underlying":"Ordinary Shares","underlying_shares":9494},"source":{"system":"sec-edgar","filing":"0001437749-20-013987","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1284839/000143774920013987/rdgdoc.xml","form_type":"4"}},{"id":3098369,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2020-06-26T20:05:11.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":4081,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4081,"source":{"system":"sec-edgar","filing":"0001437749-20-013987","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1284839/000143774920013987/rdgdoc.xml","form_type":"4"}},{"id":3138919,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2020-05-21T20:31:25.000Z","date":"2020-05-20","kind":"purchase","acquired":true,"shares":4000,"price":12.48,"value":49920.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported for the purchase on May 20, 2020 is a weighted average price.  These shares were purchased in multiple transaction at prices ranging from $12.48 to $12.49 per share, inclusive.  The reporting person undertakes to provide Oxford Immunotec Global PLC, or any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) of this Form 4."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001437749-20-011569","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1284839/000143774920011569/rdgdoc.xml","form_type":"4"}},{"id":3142401,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-19T22:15:06.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders. In the event of a change of control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such change in control."}],"balance_after":14000,"derivative":{"exercise_price":11.22,"expiration_date":"2030-05-14","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-20-030665","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1284839/000120919120030665/doc4.xml","form_type":"4"}},{"id":3483917,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true}}],"security":"SHARE OPTION (RIGHT TO BUY)","published_at":"2019-06-19T20:30:39.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":7457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the underlying shares on the date of the first annual meeting of the issuer's shareholders held after the date of grant."}],"balance_after":7457,"derivative":{"exercise_price":14.44,"expiration_date":"2029-06-18","underlying":"ORDINARY SHARES","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001437749-19-012283","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1284839/000143774919012283/rdgdoc.xml","form_type":"4"}},{"id":3885969,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true}}],"security":"SHARE OPTION (RIGHT TO BUY)","published_at":"2018-06-21T20:30:38.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":7457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the underlying shares on the date of the first annual meeting of the issuer's shareholders held after the date of grant."}],"balance_after":7457,"derivative":{"exercise_price":14.49,"expiration_date":"2028-06-19","underlying":"ORDINARY SHARES","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001437749-18-012233","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1284839/000143774918012233/rdgdoc.xml","form_type":"4"}},{"id":4288210,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":36306,"kind":"person","name":"BALTHROP PATRICK J","position":1,"cik":"0001284839","reported_name":"BALTHROP PATRICK J","relationship":{"director":true}}],"security":"SHARE OPTION (RIGHT TO BUY)","published_at":"2017-06-08T20:33:37.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":7457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the underlying shares on the date of the first annual meeting of the issuer's shareholders held after the date of grant."}],"balance_after":7457,"derivative":{"exercise_price":14.46,"expiration_date":"2027-06-06","underlying":"ORDINARY SHARES","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001437749-17-010975","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1284839/000143774917010975/rdgdoc.xml","form_type":"4"}}]}